chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Giant cell arteritis. Symptoms started 2 days after COVID with upper back and neck pain, lymph node enlargement and tenderness, TMJ pain/trimus. After second dose of Moderna vaccine, worsening sympotms with intermittent sharp lancing pain behind right ear, right >left frontal headache, lancing pain on forehead that radiated to back of head, scalp tenderness, no vision changes or temporal artery tenderness. Labs, exams, CT head and MRI/MRA head done. Video, telephone, office visit, ER visits.  Prednisone started. Temporal artery ultrasound negative. Temporal artery biopsy consistent with temporal arteritis. Symptoms improved with prednisone.
pt recvd vax & devel severe sharp h/a, severe high BP & brain/motor function was dec; sx dec p/2 months & the BP was controlled w/Cardura;
Previously well controlled non-insulin dependent type 2 diabetic (A1c 6.9 on 12/10/2020) developed polydipsia, polyuria, extreme fatigue, feeling off balance to point he does not feel comfortable driving (son drove him to appt). CBGs 330s-530s since. Less than 1 mo ago when here for DM his CBGs were 115-130s. No other medication, dietary changes, or illness to account for the abrupt change. Also reports he had vision loss on drive home following the vaccine administration. Vision loss resolved spontaneously after approx. 30 min. Presented to clinic for evaluation 01/05/21 for above listed symptoms. Concern for possible HHS/DKA so was sent to ER. Labs ruled out DKA/HHS, was given IVF and insulin, discharged home to to follow up in next few days.
Pt. C/O blurred vision peripherally in both eyes. She denied Hx of migraines, did not have any headache. No other symptoms
Vomited x 2 approx 1 1/2 hours after receiving vaccines. Temp 102.6 upon return to office 3 hr. after vaccines.
soreness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 10Feb2021 at 10:00 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Diabetes 2" (unspecified if ongoing). There were no concomitant medications.  The following information was reported: PAIN (non-serious), outcome "recovered", described as "soreness". Therapeutic measures were not taken as a result of pain.  Additional information: The patient did not have COVID prior vaccination. The patient had not been tested for COVID post-vaccination. The patient had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.